Related Experiment Video
Updated: Nov 2, 2025

07:27
Olfactory Assays for Mouse Models of Neurodegenerative Disease
Published on: August 25, 2014
22.3K
Use of coffee grounds to test olfaction for predicting cognitive dysfunction and decline
Alexander J Rajic1, Peter S Pressman2, Jonathan H Woodcock2
1University of Colorado, Anschutz Medical Campus, Department of Neurology, 12469 East 17(th) Place, Aurora, CO 80045, United States of America.
Journal of the Neurological Sciences
|June 10, 2021
Summary
Non-standardized olfactory testing (nSOIT) can help predict cognitive decline in patients with neurobehavioral disorders. Impaired smell identified through nSOIT is a sensitive, though not specific, indicator of future cognitive decline.
Area of Science:
- Neuroscience
- Gerontology
- Clinical Neurology
Background:
- Cognitive dysfunction and decline are significant concerns in neurobehavioral disorders.
- Early prediction of cognitive decline is crucial for timely intervention.
- Olfactory function is increasingly recognized as a potential early biomarker for neurological conditions.
Purpose of the Study:
- To investigate if non-standardized testing of olfaction (nSOIT) can predict cognitive dysfunction and decline.
- To assess the utility of a simple olfactory test in patients presenting with cognitive complaints.
- To determine the predictive value of olfactory impairment for cognitive decline in a neurobehavioral disorder cohort.
Main Methods:
- Cross-sectional and longitudinal analyses of 82 patients with cognitive deficits.
- Non-standardized odor identification testing (nSOIT) using coffee grounds.
- Correlation of nSOIT results with Montreal Cognitive Assessment (MoCA) scores and cognitive decline over time using mixed effects multiple regression.
Main Results:
- No association was found between initial nSOIT performance and objective cognitive dysfunction in the cross-sectional analysis.
- Impaired olfaction on follow-up nSOIT testing was a sensitive but nonspecific predictor of cognitive decline in the longitudinal analysis.
Conclusions:
- Routine olfactory testing, even when non-standardized, may be a valuable clinical tool.
- nSOIT can aid clinicians in predicting cognitive dysfunction and decline in patients with neurobehavioral disorders.
- Olfactory assessment offers a convenient and accessible method for risk stratification.
Related Concept Videos
Olfaction
46.4K
The sense of smell is achieved through the activities of the olfactory system. It starts when an airborne odorant enters the nasal cavity and reaches olfactory epithelium (OE). The OE is protected by a thin layer of mucus, which also serves the purpose of dissolving more complex compounds into simpler chemical odorants. The size of the OE and the density of sensory neurons varies among species; in humans, the OE is only about 9-10 cm2.
The olfactory receptors are embedded in the cilia of the...
The olfactory receptors are embedded in the cilia of the...
46.4K
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
270
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
270

